HIGHLIGHTS
- who: Reducing Carbamazepine/ et al. from the Adverse Drug Reactions in Thailand University of the West Indies, Jamaica have published the research: Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/ Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand, in the Journal: (JOURNAL)
- what: The aim of this study was to investigate how PGx testing (HLA-B*15:02) affected the CBZ/OXC prescriptions and the Frontiers in Pharmacology | www.frontiersin.org METHODOLOGY Study Population This was a retrospective cohort study conducted at the Ramathibodi Hospital of the Faculty of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.